CALCULATE YOUR SIP RETURNS

IPOs - Angel One

placeholder

Unicommerce E Solutions IPO to Open from August 6

1 August 2024

Incorporated in February 2012, Unicommerce eSolutions Limited is a Software-as-a-Service (SaaS) platform that specializes in managing e-commerce operations for brands, sellers, and logistics providers. The company offers a wide range of software products designed to streamline and optimize post-purchase e-commerce processes. These include a warehouse and inventory management system, a multi-channel order management system, an …

placeholder

Upcoming IPOs in August 2024

29 July 2024

On Monday, Indian markets opened on a positive note. The Sensex is trading 0.43% higher at 81,683.42, while the Nifty has risen by 0.35% to 24,922.50. The broader indices also saw a rally, with the Nifty Mid-cap up 0.66% and the Nifty Small-cap up 0.91%. India VIX has zoomed by 4.29%, indicating increased market volatility. …

placeholder

Ceigall IPO to Open for Subscription on August 1st

29 July 2024

Founded in 2002, Ceigall India Limited specializes in infrastructure construction with a focus on specialized structural projects. These projects include elevated roads, flyovers, bridges, railway overpasses, tunnels, highways, expressways, and runways. By July 2024, the company had completed over 34 road and highway projects, including 16 EPC projects, one HAM project, five O&M projects, and …

placeholder

Sanstar Lists at 15% Premium at Rs 109 per share on BSE!

26 July 2024

Founded in 1982, Sanstar Limited specializes in producing plant-based ingredients and solutions for food, pet food, and industrial applications in India, debuted on the stock market today. The company’s stock settled at Rs 106.40 per share on the BSE, representing an impressive 12% premium over the final issue price of Rs 95 per share. Additionally, …

placeholder

Akum Drugs IPO to Open on July 30, Price Band Set At Rs.646-679 Per Share

25 July 2024

Akums Drugs and Pharmaceuticals Limited is a leading pharmaceutical contract development and manufacturing organization (CDMO) that provides extensive pharmaceutical products and services in India and internationally. The company offers end-to-end solutions for product development, manufacturing, and R&D of formulations. It prepares and submits regulatory dossiers for both Indian and global markets and provides various testing …

placeholder

NSE Introduces 90% Price Cap on SME IPOs: Pros and Cons

4 July 2024

Introduction The National Stock Exchange of India Ltd. (NSE) has announced a significant regulatory change aimed at standardizing the price discovery mechanism for Initial Public Offers (IPOs) on the SME platform. This article delves into the details of this new measure, its implications, both positive and negative, and the reasons behind its implementation. The New …

placeholder

Bansal Wire Industries Lists at 39% Premium at Rs 356 per share on NSE!

10 July 2024

Bansal Wire Industries Limited specializes in manufacturing stainless steel wire, debuted on the Indian stock market today. The stock of Bansal Wire Industries settled at Rs 352.05 per share on the BSE, representing an impressive 37.52% premium over the final issue price of Rs 256 per share. Additionally, on the NSE, the company’s shares opened …

placeholder

Emcure Pharma IPO Listed At 31.5% Premium

10 July 2024

Emcure Pharma’s successful debut impressed investors and analysts on the stock exchange, reflecting strong confidence in the company’s growth prospects and management team. The premium opening price of Rs. 1325.05 indicated strong demand for the stock, with investors eager to capitalize on Emcure Pharma’s potential in the pharmaceutical industry. This strong outlook for the stock …

placeholder

SEBI Delays Crizac Ltd.’s Rs.1000 Cr IPO

23 July 2024

Crizac Ltd., a student recruitment solution provider based in Kolkata, has encountered a significant hurdle in its plans to launch a Rs 1,000-crore initial public offering (IPO). The Securities and Exchange Board of India (SEBI) has returned the draft documents, causing a delay in the company’s initial share sale. This IPO was intended to be …

placeholder

Stallion India Fluorochemicals Secures SEBI Approval for IPO

23 July 2024

Stallion India Fluorochemicals has received the green light from the Securities and Exchange Board of India (SEBI) to raise capital through an initial public offering (IPO). The company plans to issue new equity shares and conduct an offer-for-sale, as detailed in their draft red herring prospectus. IPO Details and Allocation of Funds Stallion India Fluorochemicals …

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Open Free Demat Account!
Join our 3 Cr+ happy customers